Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 2/2019

01-04-2019 | Case Report

Chronic intestinal pseudo-obstruction due to al amyloidosis: a case report and literature review

Authors: Tomoya Iida, Daisuke Hirayama, Gota Sudo, Kei Mitsuhashi, Hisayoshi Igarashi, Kentaro Yamashita, Hiroo Yamano, Hiroshi Nakase

Published in: Clinical Journal of Gastroenterology | Issue 2/2019

Login to get access

Abstract

A 59-year-old woman presented to our hospital with a 6-month history of nausea, weight loss, and abdominal distension. Physical examination revealed abdominal distension without tenderness, and edema, numbness, and multiple peripheral neuropathy in the limbs. Blood test results showed anemia, hypoproteinemia, and hypoalbuminemia. Immunoelectrophoresis detected kappa-type Bence-Jones protein in both the serum and urine. Bone marrow examination did not reveal an increase of plasma cells. Computed tomography showed intestinal distension and retention of intestinal contents. No obstructive intestinal lesions were observed. Lower gastrointestinal endoscopy showed a decrease in the vascular visibility of the rectal mucosa. Histological findings showed amyloid deposition, which was positive for amyloid light-chain (AL) κ. Thus, she was diagnosed with chronic intestinal pseudo-obstruction (CIPO) due to gastrointestinal and neurological involvement of AL amyloidosis. Her abdominal symptoms were gradually improved by the insertion of an ileus tube and medication. Although we recommended chemotherapy for stopping her disease progression, she did not want to receive it. She died 1 year later because of her pneumonia. We should keep in mind that amyloidosis is an important cause of CIPO. Histopathological examination by endoscopic biopsy is required for exact diagnosis and appropriate treatment for CIPO due to amyloidosis.
Literature
1.
go back to reference Dudley HA, Sinclair IS, McLaren IF, et al. Intestinal pseudo-obstruction. J R Coll Surg Edinb. 1958;3:206–17.PubMed Dudley HA, Sinclair IS, McLaren IF, et al. Intestinal pseudo-obstruction. J R Coll Surg Edinb. 1958;3:206–17.PubMed
2.
go back to reference Stanghellini V, Cogliandro RF, de Giorgio R, et al. Chronic intestinal pseudo-obstruction; manifestations, natural history and management. Neurogastroenterol Motil. 2007;19:440–52.CrossRefPubMed Stanghellini V, Cogliandro RF, de Giorgio R, et al. Chronic intestinal pseudo-obstruction; manifestations, natural history and management. Neurogastroenterol Motil. 2007;19:440–52.CrossRefPubMed
3.
go back to reference Connor FL, Di Lorenzo C. Chronic intestinal pseudo-obstruction: assessment and management. Gastroenterology. 2006;130:29–36.CrossRef Connor FL, Di Lorenzo C. Chronic intestinal pseudo-obstruction: assessment and management. Gastroenterology. 2006;130:29–36.CrossRef
4.
go back to reference Sipe JD, Benson MD, Buxbaum JN, et al. Nomenclature 2014: amyloid fibril proteins and clinical classification of the amyloidosis. Amyloid. 2014;21:221–4.CrossRefPubMed Sipe JD, Benson MD, Buxbaum JN, et al. Nomenclature 2014: amyloid fibril proteins and clinical classification of the amyloidosis. Amyloid. 2014;21:221–4.CrossRefPubMed
5.
go back to reference Iida T, Yamano H, Nakase H. Systemic amyloidosis with gastrointestinal involvement: diagnosis from endoscopic and histological views. J Gastroenterol Hepatol. 2018;33:583–90.CrossRefPubMed Iida T, Yamano H, Nakase H. Systemic amyloidosis with gastrointestinal involvement: diagnosis from endoscopic and histological views. J Gastroenterol Hepatol. 2018;33:583–90.CrossRefPubMed
6.
go back to reference Tada S, Iida M, Iwashita A, et al. Endoscopic and biopsy findings of the upper digestive tract in patients with amyloidosis. Gastrointest Endosc. 1990;36:10–4.CrossRefPubMed Tada S, Iida M, Iwashita A, et al. Endoscopic and biopsy findings of the upper digestive tract in patients with amyloidosis. Gastrointest Endosc. 1990;36:10–4.CrossRefPubMed
7.
go back to reference Lim AY, Lee JH, Jung KS, et al. Clinical features and outcomes of systemic amyloidosis with gastrointestinal involvement: a single-center experience. Korean J Intern Med. 2015;30:496–505.CrossRefPubMedPubMedCentral Lim AY, Lee JH, Jung KS, et al. Clinical features and outcomes of systemic amyloidosis with gastrointestinal involvement: a single-center experience. Korean J Intern Med. 2015;30:496–505.CrossRefPubMedPubMedCentral
8.
go back to reference Freudenthaler S, Hegenbart U, Schönland S, et al. Amyloid in biopsies of the gastrointestinal tract—a retrospective observational study on 542 patients. Virchows Arch. 2016;468:569–77.CrossRefPubMedPubMedCentral Freudenthaler S, Hegenbart U, Schönland S, et al. Amyloid in biopsies of the gastrointestinal tract—a retrospective observational study on 542 patients. Virchows Arch. 2016;468:569–77.CrossRefPubMedPubMedCentral
10.
go back to reference Yilmaz M, Unsal A, Sokmen M, et al. Duodenal biopsy for diagnosis of renal involvement in amyloidosis. Clin Nephrol. 2012;77:114–8.CrossRefPubMed Yilmaz M, Unsal A, Sokmen M, et al. Duodenal biopsy for diagnosis of renal involvement in amyloidosis. Clin Nephrol. 2012;77:114–8.CrossRefPubMed
11.
go back to reference Hayman SR, Lacy MQ, Kyle RA, et al. Primary systemic amyloidosis: a cause of malabsorption syndrome. Am J Med. 2001;111:535–40.CrossRefPubMed Hayman SR, Lacy MQ, Kyle RA, et al. Primary systemic amyloidosis: a cause of malabsorption syndrome. Am J Med. 2001;111:535–40.CrossRefPubMed
12.
go back to reference Milivojevic V, Stojanovic M, Rankovic I, et al. Multiple myeloma associated intestinal amyloidosis: intestinal pseudoobstruction falsely considered as an ascites. Rev Recent Clin Trials. 2018;13:79–81.CrossRefPubMed Milivojevic V, Stojanovic M, Rankovic I, et al. Multiple myeloma associated intestinal amyloidosis: intestinal pseudoobstruction falsely considered as an ascites. Rev Recent Clin Trials. 2018;13:79–81.CrossRefPubMed
14.
go back to reference Kim YJ, Kim HS, Park SY, et al. Intestinal amyloidosis with intractable diarrhea and intestinal pseudo-obstruction. Korean J Gastroenterol. 2012;60:172–6.CrossRefPubMed Kim YJ, Kim HS, Park SY, et al. Intestinal amyloidosis with intractable diarrhea and intestinal pseudo-obstruction. Korean J Gastroenterol. 2012;60:172–6.CrossRefPubMed
15.
go back to reference Liapis K, Michelis FV, Delimpasi S, et al. Intestinal pseudo-obstruction associated with amyloidosis. Amyloid. 2011;18:76–8.CrossRefPubMed Liapis K, Michelis FV, Delimpasi S, et al. Intestinal pseudo-obstruction associated with amyloidosis. Amyloid. 2011;18:76–8.CrossRefPubMed
16.
go back to reference Fonnesu C, Giovinale M, Verrecchia E, et al. Gastrointestinal amyloidosis: a case of chronic diarrhoea. Eur Rev Med Pharmacol Sci. 2009;13:45–50.PubMed Fonnesu C, Giovinale M, Verrecchia E, et al. Gastrointestinal amyloidosis: a case of chronic diarrhoea. Eur Rev Med Pharmacol Sci. 2009;13:45–50.PubMed
17.
go back to reference Hurlstone DP. Iron-deficiency anemia complicating AL amyloidosis with recurrent small bowel pseudo-obstruction and hindgut sparing. J Gastroenterol Hepatol. 2002;17:623–4.CrossRefPubMed Hurlstone DP. Iron-deficiency anemia complicating AL amyloidosis with recurrent small bowel pseudo-obstruction and hindgut sparing. J Gastroenterol Hepatol. 2002;17:623–4.CrossRefPubMed
18.
go back to reference Deguchi M, Shiraki K, Okano H, et al. Primary localized amyloidosis of the small intestine presenting as an intestinal pseudo-obstruction: report of a case. Surg Today. 2001;31:1091–3.CrossRefPubMed Deguchi M, Shiraki K, Okano H, et al. Primary localized amyloidosis of the small intestine presenting as an intestinal pseudo-obstruction: report of a case. Surg Today. 2001;31:1091–3.CrossRefPubMed
19.
go back to reference Kanai H, Kashiwagi M, Hirakata H, et al. Chronic intestinal pseudo-obstruction due to dialysis-related amyloid deposition in the propria muscularis in a hemodialysis patient. Clin Nephrol. 2000;53:394–9.PubMed Kanai H, Kashiwagi M, Hirakata H, et al. Chronic intestinal pseudo-obstruction due to dialysis-related amyloid deposition in the propria muscularis in a hemodialysis patient. Clin Nephrol. 2000;53:394–9.PubMed
20.
go back to reference Hiramatsu K, Kaneko S, Shirota Y, et al. Gastrointestinal amyloidosis secondary to hypersensitivity vasculitis presenting with intestinal pseudoobstruction. Dig Dis Sci. 1998;43:1824–30.CrossRefPubMed Hiramatsu K, Kaneko S, Shirota Y, et al. Gastrointestinal amyloidosis secondary to hypersensitivity vasculitis presenting with intestinal pseudoobstruction. Dig Dis Sci. 1998;43:1824–30.CrossRefPubMed
21.
go back to reference Borczuk A, Mannion C, Dickson D, et al. Intestinal pseudo-obstruction and ischemia secondary to both beta 2-microglobulin and serum A amyloid deposition. Mod Pathol. 1995;8:577–82.PubMed Borczuk A, Mannion C, Dickson D, et al. Intestinal pseudo-obstruction and ischemia secondary to both beta 2-microglobulin and serum A amyloid deposition. Mod Pathol. 1995;8:577–82.PubMed
22.
go back to reference Fraser AG, Arthur JF, Hamilton I. Intestinal pseudoobstruction secondary to amyloidosis responsive to cisapride. Dig Dis Sci. 1991;36:532–5.CrossRefPubMed Fraser AG, Arthur JF, Hamilton I. Intestinal pseudoobstruction secondary to amyloidosis responsive to cisapride. Dig Dis Sci. 1991;36:532–5.CrossRefPubMed
23.
go back to reference Tada S, Iida M, Yao T, et al. Intestinal pseudo-obstruction in patients with amyloidosis: clinicopathologic differences between chemical types of amyloid protein. Gut. 1993;34:1412–7.CrossRefPubMedPubMedCentral Tada S, Iida M, Yao T, et al. Intestinal pseudo-obstruction in patients with amyloidosis: clinicopathologic differences between chemical types of amyloid protein. Gut. 1993;34:1412–7.CrossRefPubMedPubMedCentral
25.
go back to reference Westermark GT, Fändrich M, Westermark P. AA amyloidosis: pathogenesis and targeted therapy. Annu Rev Pathol. 2015;10:321–44.CrossRefPubMed Westermark GT, Fändrich M, Westermark P. AA amyloidosis: pathogenesis and targeted therapy. Annu Rev Pathol. 2015;10:321–44.CrossRefPubMed
26.
go back to reference Amiot A, Jolly F, Alves A, et al. Long-term outcome of chronic intestinal pseudo-obstruction adult patients requiring home parenteral nutrition. Am J Gastroenterol. 2009;104:1262–70.CrossRefPubMed Amiot A, Jolly F, Alves A, et al. Long-term outcome of chronic intestinal pseudo-obstruction adult patients requiring home parenteral nutrition. Am J Gastroenterol. 2009;104:1262–70.CrossRefPubMed
27.
go back to reference Pironi L, Joly F, Forbes A, et al. Long-term follow-up of patients on home parenteral nutrition in Europe: implication for intestinal transplantation. Gut. 2011;60:17–25.CrossRefPubMed Pironi L, Joly F, Forbes A, et al. Long-term follow-up of patients on home parenteral nutrition in Europe: implication for intestinal transplantation. Gut. 2011;60:17–25.CrossRefPubMed
28.
go back to reference Rao AS, Camilleri M. Metoclopramide and tardive dyskinesia. Aliment Pharmacol Ther. 2010;31:11–9.CrossRefPubMed Rao AS, Camilleri M. Metoclopramide and tardive dyskinesia. Aliment Pharmacol Ther. 2010;31:11–9.CrossRefPubMed
29.
go back to reference Emmanuel AV, Shand AG, Kamm MA. Erythromycin for the treatment of chronic intestinal pseudo-obstruction: description of six cases with a positive response. Aliment Pharmacol Ther. 2004;19:687–94.CrossRefPubMed Emmanuel AV, Shand AG, Kamm MA. Erythromycin for the treatment of chronic intestinal pseudo-obstruction: description of six cases with a positive response. Aliment Pharmacol Ther. 2004;19:687–94.CrossRefPubMed
30.
go back to reference O’Dea CJ, Brookes JH, Wattchow DA. The efficacy of treatment of patients with severe constipation or recurrent pseudo-obstruction with pyridostigmine. Colorectal Dis. 2010;12:540–8.CrossRefPubMed O’Dea CJ, Brookes JH, Wattchow DA. The efficacy of treatment of patients with severe constipation or recurrent pseudo-obstruction with pyridostigmine. Colorectal Dis. 2010;12:540–8.CrossRefPubMed
31.
go back to reference Emmanuel AV, Kamm MA, Roy AJ, et al. Randomised clinical trial: the efficacy of prucalopride in patients with chronic intestinal pseudo-obstruction—a double-blind, placebo-controlled, cross-over, multiple n = 1 study. Aliment Pharmacol Ther. 2012;35:48–55.CrossRefPubMed Emmanuel AV, Kamm MA, Roy AJ, et al. Randomised clinical trial: the efficacy of prucalopride in patients with chronic intestinal pseudo-obstruction—a double-blind, placebo-controlled, cross-over, multiple n = 1 study. Aliment Pharmacol Ther. 2012;35:48–55.CrossRefPubMed
Metadata
Title
Chronic intestinal pseudo-obstruction due to al amyloidosis: a case report and literature review
Authors
Tomoya Iida
Daisuke Hirayama
Gota Sudo
Kei Mitsuhashi
Hisayoshi Igarashi
Kentaro Yamashita
Hiroo Yamano
Hiroshi Nakase
Publication date
01-04-2019
Publisher
Springer Japan
Published in
Clinical Journal of Gastroenterology / Issue 2/2019
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-018-0909-6

Other articles of this Issue 2/2019

Clinical Journal of Gastroenterology 2/2019 Go to the issue